Mediaplanet’s “Personalized Medicine” Campaign Illuminates the Cutting Edge in Medicine and Precision Treatment

Share Article

Mediaplanet today announces distribution of its first cross-platform edition of “Personalized Medicine.” This campaign will empower patients who are suffering from cancer, cardiovascular illnesses, neurological disorders and other diseases, bringing much needed awareness and education to the masses about this new and emerging field of medicine.

News Image

In collaboration with leading organizations, we aim to increase support publicly, politically and financially, ultimately allowing those who are moving research and development forward the chance to do so for the health of all Americans.

The print component of “Personalized Medicine” is distributed within this weekend’s edition of USA Today in New York, Los Angeles and Washington DC/Baltimore, with a circulation of approximately 250,000 copies and an estimated readership of 750,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign,click here.

This campaign was made possible with the support of the Personalized Medicine Coalition, National Institutes of Health, Personalized Medicine Initiative, Health and Human Services, Myriad Genetics, CompanionDx, Oracle Health Sciences, Amicus Therapeutics, Labcyte, Geneticure, Silicon Biosystems, OmniSeq and many more.

About Mediaplanet

Mediaplanet is the leading independent publisher of content-marketing campaigns covering a variety of topics and industries. We turn consumer interest into action by providing readers with motivational editorial, pairing it with relevant advertisers and distributing it within top newspapers and online platforms around the world.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jessica Guggenheimer
Follow >
Visit website